US Drug Recall Register

FDA Drug Recalls

2,661 recalls, newest first

Class III · Low risk Ongoing

Glimepiride Tablets

Reason Misprint on tablet

Dr. Reddy's Laboratories, Inc. D-0312-2024
Class II · Moderate risk Ongoing

Hydrogen Peroxide Oral Rinse

Reason CGMP Deviations: products may not conform to the labeled specifications.

Den-Mat Holdings, LLC NDC 59883-202-16 D-0287-2024
Class II · Moderate risk Ongoing

OralProCare medicated lip treatment

Reason CGMP Deviations: products may not conform to the labeled specifications.

Den-Mat Holdings, LLC NDC 59883-500-01 D-0286-2024
Class I · High risk Ongoing

Neptune's Fix

Reason Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.

Neptune Resources, LLC D-0335-2024
Class I · High risk Ongoing

Neptune's Fix

Reason Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.

Neptune Resources, LLC D-0334-2024
Class I · High risk Ongoing

Neptune's Fix

Reason Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.

Neptune Resources, LLC D-0333-2024
Class II · Moderate risk Ongoing

Vasostrict

Reason Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.

Par Sterile Products LLC D-0232-2024
Class II · Moderate risk Ongoing

Medline Remedy Clinical TREAT Antifungal Cream

Reason Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list.

MEDLINE INDUSTRIES, LP - Northfield D-0315-2024
Class II · Moderate risk Ongoing

Ibuprofen and Famotidine Tablets 800mg/26.6mg

Reason Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.

Ascend Laboratories, LLC NDC 67877-626-90 D-0237-2024
Class I · High risk Ongoing

PHENYLephrine HCl 40 mg per 250 mL 0.9% Sodium Chloride

Reason Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Denver Solutions, LLC DBA Leiters Health NDC 71449-150-82 D-0280-2024
Class I · High risk Ongoing

PHENYLephrine HCl 20 mg per 250 mL 0.9% Sodium Chloride

Reason Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Denver Solutions, LLC DBA Leiters Health NDC 71449-148-94 D-0279-2024
Class I · High risk Ongoing

FentaNYL citrate PF

Reason Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Denver Solutions, LLC DBA Leiters Health NDC 71449-072-82 D-0278-2024
Class I · High risk Ongoing

FentaNYL citrate PF

Reason Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Denver Solutions, LLC DBA Leiters Health NDC 71449-072-41 D-0277-2024
Class II · Moderate risk Ongoing

Quality Choice No Drip Severe Congestion Nasal Pump Mist

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. NDC 63868-608-01 D-0217-2024
Class II · Moderate risk Ongoing

Quality Choice No Drip Extra Moisturizing Nasal Pump Mist…

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. NDC 63868-676-01 D-0216-2024
Class II · Moderate risk Ongoing

Premier Value Tussin Cough DM

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. D-0215-2024
Class II · Moderate risk Ongoing

Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. NDC 63868-607-01 D-0214-2024